Maternal oxygen administration for fetal distress
Rosser, J.
Practising Midwife 2(10): 10
1999
ISSN/ISBN: 1461-3123 PMID: 12024548 Document Number: 499280
Document emailed within 1 workday
Related Documents
Dodion, J. 1970: The variations of arterial tensions in oxygen and carbonic anhydride in premature during respiratory distress. Effects of 40 percent oxygen administration Pediatrie 25(2): 161-172Gimovsky, M.L. 1990: Fetal heart rate monitoring casebook. Successful treatment of fetal hypoxemia in chronic anemia by artificially increasing maternal oxygen-carrying capacity Journal of Perinatology: Official Journal of the California Perinatal Association 10(2): 198-201
Jurow, R.; Paul, R.H. 1984: Cesarean delivery for fetal distress without maternal consent Obstetrics and Gynecology 63(4): 596-599
Brigato, G.; Magnabosco, R.; Ilacqua, N. 1972: Feto-maternal macrotransfusion as a cause of fetal and neonatal distress Minerva Ginecologica 24(10): 555-557
Rurak, D.W.; Yoo, S.D.; Kwan, E.; Taylor, S.M.; Riggs, K.W.; Axelson, J.E. 1988: Effects of diphenhydramine in the fetal lamb after maternal or fetal administration Journal of Pharmacology and Experimental Therapeutics 247(1): 271-278
Scarpelli, P.T.; Fersini, C.; Sensi, G.; Corti, C.; Croppi, E.; Romano, S.; Tarquini, B. 1984: The maternal 24-h blood pressure (BP) profile as a predictor of fetal distress Chronobiologia 11(2): 141-145
Wauer, R.R.; Grauel, E.L.; Hengst, P. 1976: Prevention of neonatal respiratory distress syndrome through the administration of prednisolone in the fetal period Zentralblatt für Gynakologie 98(13): 769-773
Haruta, M.; Funato, T.; Sumida, T.; Shinkai, T. 1984: The influence of maternal oxygen inhalation for 30 to 60 minutes on fetal oxygenation Nihon Sanka Fujinka Gakkai Zasshi 36(10): 1921-1929
Reich, I.; Kůs, K.; Správka, V. 1981: Rational administration of oxygen during labor when there are signs of fetal hypoxia Ceskoslovenska Gynekologie 46(8): 624-626
Haruta, M.; Funato, T.; Naka, Y.; Saeki, N. 1988: Effects of maternal hyperventilation and oxygen inhalation during labor on fetal blood-gas status Nihon Sanka Fujinka Gakkai Zasshi 40(9): 1377-1384
Fernandez, H.; Bourget, P.; Delouis, C. 1990: Fetal levels of tobramycin following maternal administration Obstetrics and Gynecology 76(5 Part 2): 992-994
al-Harbi, M.M.; al-Shabanah, O.A.; al-Gharably, N.M.; Islam, M.W. 1992: The effect of maternal administration of enalapril on fetal development in the rat Research Communications in Chemical Pathology and Pharmacology 77(3): 347-358
Spinapolice, R.X.; Wallace, D.; Kennedy, P. 1983: Fetal distress secondary to fetal vessel perforation after amniocentesis. A case report Journal of Reproductive Medicine 28(8): 551-553
Treisser, A.; Sureau, C. 1981: Current means of fetal monitoring. The concept of chronic fetal distress La Revue du Praticien 31(5): 329
Craig, S.; Easton, M. 1998: Intrauterine fetal volvulus presenting as fetal distress on cardiotocographic monitoring: a case report Journal of Perinatal Medicine 26(3): 244-247
Destro, F.; Spanio, P.; Segata, L.; Cubesi, G.; Capozzi, A.; Inzirillo, G. 1972: Possibilities of the therapeutic use of general anesthesia during labor with fetal distress and studies on fetal and neonatal homeostasis. 2 Minerva Ginecologica 24(3): 127-132
Wright, A.J. 1989: Fetal arrhythmia masquerading as fetal distress. A case report Journal of Reproductive Medicine 34(4): 301-302
Daffos, F.; Forestier, F.; Nahoul, K.; Castanier, M.; Capella-Pavlovsky, M.; Chartier, M.; Scholler, R. 1984: Fetal hormonology by direct sampling of fetal blood during the 2d trimester of pregnancy. Study of fetal and maternal 5-ene steroid sulfates Pathologie-Biologie 32(8): 891-894
Miyamura, T. 1994: The relationship of amniotic fluid volume and fetal renal function to fetal distress in intrauterine growth retardation Nihon Sanka Fujinka Gakkai Zasshi 46(9): 861-866
Sandberg, J.A.; Olsen, G.D. 1992: Cocaine and metabolite concentrations in the fetal guinea pig after chronic maternal cocaine administration Journal of Pharmacology and Experimental Therapeutics 260(2): 587-591